Spinal Cord Injury Related Osteoporosis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2020-10-22
Clinical Trial Update: Evaluation of Romosozumab vs. Zoledronic Acid Effect in Patients With Spinal Cord Injury and Low Bone Mineral Density [Phase 4]
Phase 4 trial evaluating romosozumab versus zoledronic acid for osteoporosis with spinal cord injury-related low bone density.